Financial Performance - Full year 2024 net sales were 133.5 million, or 2%, compared to 2023[19] - Full year 2024 net income was 2.58 per diluted share, down from 2.98 per diluted share in 2023[2] - Adjusted net income per diluted share for 2024 was 3.40 in 2023[3] - Silgan Holdings reported annual net sales of approximately 5.988 billion in 2023, representing a decline of about 2.2%[34] - The company’s net income for 2024 was 326 million in 2023, marking a decrease of approximately 15.2%[42] - Diluted earnings per share (EPS) for 2024 was 2.98 in 2023, reflecting a decline of about 13.4%[38] Quarterly Performance - Fourth quarter 2024 net sales were 71.1 million, or 5%, year-over-year[9] - For the fourth quarter of 2024, net sales were 1.340 billion in the same quarter of 2023, reflecting an increase of approximately 5.3%[38] - U.S. GAAP net income for Q4 2024 was 0.42, compared to 0.60 in Q4 2023, representing a decrease of 30% in net income and 30% in EPS[46] - Non-U.S. GAAP adjusted net income for Q4 2024 was 0.85, compared to 0.63 in Q4 2023, indicating an increase of 34% in adjusted net income and 35% in adjusted EPS[46] - Total adjusted EBIT for Q4 2024 was 135.9 million in Q4 2023, reflecting an increase of 11%[48] - Adjusted EBIT for the Dispensing and Specialty Closures segment in Q4 2024 was 87.0 million in Q4 2023, an increase of 15%[48] Cash Flow and Assets - Free cash flow for 2024 was 356.7 million in 2023[23] - The company reported a net cash provided by operating activities of 482.6 million in 2023, showing an increase of about 49.6%[41] - Cash and cash equivalents increased to 642.9 million in 2023, representing a growth of approximately 28%[40] - Silgan's total assets grew to 7.611 billion in 2023, an increase of approximately 12.8%[40] - Free cash flow for the year ended 2024 was 356.7 million in 2023, marking an increase of 10%[52] - Net cash provided by operating activities for 2024 was 482.6 million in 2023, representing a growth of 50%[52] Future Expectations - The Company anticipates adjusted net income per diluted share for 2025 to be in the range of 4.20, a 13% increase at the midpoint over 2024[30] - The company expects free cash flow in 2025 to be approximately 66.4 million and 0.62 to 59.5 million in 2024, compared to 57.9 million for Q4 2024, compared to 262.8 million, up from $226.8 million in 2023, indicating a rise of approximately 15.9%[41] - The weighted average number of diluted shares outstanding for 2024 was 107.1 million, compared to 109.2 million in 2023, reflecting a decrease of 2%[52] Non-GAAP Measures - The Company presented adjusted net income per diluted share as a Non-GAAP financial measure, excluding acquired intangible asset amortization expense and other pension income, which management believes provides a more accurate evaluation of operating results[53] - Adjusted EBIT was also presented as a Non-GAAP financial measure, excluding similar costs as adjusted net income, and including equity in earnings of affiliates, which management views as part of the Company's operating performance[54] - Free cash flow is defined as net cash provided by operating activities adjusted for changes in outstanding checks, reduced by capital expenditures, and increased by proceeds from asset sales, highlighting its importance for internal growth and acquisitions[56]
Silgan (SLGN) - 2024 Q4 - Annual Results